BackTable / Tumor Board / Podcast / Episode #35

NSCLC Tumor Board Discussion: Considerations for Oligometastatic Disease

with Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Oh, Dr. Alan Lee and Dr. Scott Genshaft

When cancer spreads to the brain, what is the best approach: immediate local treatment or systemic immunotherapy first? Part two of the 2025 NSCLC Creator Weekend™ series focuses on a complex case involving a 75-year-old woman with a history of breast malignancy, presenting with new dyspnea and a large mass in the left lower lobe.

This podcast is supported by an educational grant from Johnson & Johnson and Varian.

Johnson & Johnson

Varian

NSCLC Tumor Board Discussion: Considerations for Oligometastatic Disease with Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Oh, Dr. Alan Lee and Dr. Scott Genshaft on the BackTable Tumor Board Podcast

Ep 35 NSCLC Tumor Board Discussion: Considerations for Oligometastatic Disease with Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Oh, Dr. Alan Lee and Dr. Scott Genshaft

00:00 / 01:04

BackTable, LLC (Producer). (2025, November 14). Ep. 35 – NSCLC Tumor Board Discussion: Considerations for Oligometastatic Disease [Audio podcast]. Retrieved from https://www.backtable.com

Stay Up To Date

Follow:

Subscribe:

Podcast Contributors

Dr. Scott Atay

Dr. Scott Atay is a thoracic surgeon at Keck School of Medicine of the University of Southern California.

Dr. Scott Genshaft

Dr. Scott Genshaft is an interventional radiologist and the Director of Community Outpatient Interventional Radiology at UCLA Health in Los Angeles, California.

Dr. Alan Lee

Dr. Alan Lee is a radiation oncologist and Clinical Assistant Professor at UCLA Health in Los Angeles, California.

Dr. Scott Oh

Dr. Scott Oh is an interventional pulmonologist and Professor of Medicine at the University of Southern California in Los Angeles, California.

Dr. Karen Reckamp

Dr. Karen Reckamp is a Professor in Medicine, Director of the Division of Medical Oncology at Cedars-Sinai Medical Center in Los Angeles, California.

Synopsis

Our mock tumor board consists of surgeons, medical oncologists, and radiation oncologists to deliberate and determine the best treatment plan. The specialists explore diagnostic and treatment options, including neoadjuvant chemoimmunotherapy, invasive mediastinal staging, and the potential for surgical resection or radiation therapy.

Timestamps

00:00 - Introduction
05:01 - Approach to Isolated Brain Metastasis
09:09 - Radiation Therapy Considerations
12:06 - Imaging and Follow-Up Strategies
14:39 - Resectability and Surgical Decisions
19:10 - Conclusion

Resources

PACIFIC Clinical Trial
https://www.nejm.org/doi/full/10.1056/NEJMoa1709937

The Materials available on BackTable are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

Up Next

NSCLC Treatment: Bispecific Antibodies & EGFR Mutations with Dr. Wade Iams on the BackTable Tumor Board Podcast

Pulse Electrical Field Ablation: Lung Cancer Applications & Benefits with Dr. William Moore and Dr. Daniel Sterman on the BackTable Tumor Board Podcast

ESMO Update: Advances in Upper GI Malignancies with Dr. Jun Gong and Dr. Jonathan Mizrahi on the BackTable Tumor Board Podcast

ESMO Update: Trial Results & New Therapies in Colorectal Cancer with Dr. Jun Gong and Dr. Jonathan Mizrahi on the BackTable Tumor Board Podcast

Advanced Surgical Approaches in Lung Cancer Management with Dr. Scott Atay and Dr. Scott Oh on the BackTable Tumor Board Podcast

Complex HCC Patients & The "Grey Zone": What To Do When You Don’t Know What To Do with Dr. Adam Burgoyne, Dr. Zach Berman, Dr. Kirema Garcia-Reyes and Dr. Lingling Du on the BackTable Tumor Board Podcast

Articles

Topics

Non-Small Cell Lung Cancer (NSCLC) Podcasts

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.